Skip to main content

Peer Review reports

From: Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma

Original Submission
6 Feb 2025 Submitted Original manuscript
11 Feb 2025 Author responded Author comments - Rui Sun
Resubmission - Version 2
11 Feb 2025 Submitted Manuscript version 2
17 Feb 2025 Reviewed Reviewer Report
8 Mar 2025 Reviewed Reviewer Report
17 Mar 2025 Author responded Author comments - Rui Sun
Resubmission - Version 3
17 Mar 2025 Submitted Manuscript version 3
20 Mar 2025 Reviewed Reviewer Report
31 Mar 2025 Reviewed Reviewer Report
7 Apr 2025 Author responded Author comments - Rui Sun
Resubmission - Version 4
7 Apr 2025 Submitted Manuscript version 4
Publishing
8 Apr 2025 Editorially accepted
14 Apr 2025 Article published 10.1186/s12885-025-14108-w

You can find further information about peer review here.

Back to article page